Related Experiment Video
Updated: Nov 17, 2025
09:04
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
1.0K
Targeting Innate Immunity in Cancer Therapy
Srikrishnan Rameshbabu1, Brian W Labadie1, Anna Argulian1
1Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL 60637, USA.
Vaccines
|February 12, 2021
Summary
Cancer immunotherapies often fail in "cold" tumors. Activating innate immunity and combining it with adaptive strategies may overcome this, enhancing cancer treatment efficacy for more patients.
Area of Science:
- Oncology
- Immunology
- Cancer Research
Background:
- Current cancer immunotherapies, like immune checkpoint inhibitors (ICIs) targeting PD-1, PD-L1, and CTLA-4, show limited efficacy (approx. 20% response rate) primarily in
- hot
- tumors with T cell infiltration, leaving
- cold
- tumors largely untreated.
- Cold tumors develop an immunosuppressive tumor microenvironment (TME), hindering spontaneous immune responses and T cell infiltration.
Purpose of the Study:
- To review novel therapeutic strategies aimed at activating innate immunity within the TME.
- To explore approaches for enhancing antitumor immune responses, particularly in
- cold
- tumors.
- To discuss rational combination strategies that synergize innate and adaptive immunity for improved cancer treatment outcomes.
Main Methods:
- Review of therapeutic approaches targeting innate immune pathways, including pattern recognition receptors (PRRs) like Toll-like receptors (TLRs), cGAS/STING, NLRs (e.g., NLRP3), and RIG-I-like receptors (RLRs).
- Investigation of therapeutic modulation of innate immune cells such as macrophages and natural killer (NK) cells.
- Analysis of combination immunotherapies integrating innate and adaptive immune activation.
Main Results:
- Emerging strategies focus on stimulating innate immunity to overcome the immunosuppressive TME in
- cold
- tumors.
- Targeting PRRs and modulating innate immune cells shows promise for enhancing antitumor immunity.
- Combination therapies activating both innate and adaptive immunity are being explored to improve overall treatment efficacy.
Conclusions:
- Activating innate immunity is a promising strategy to enhance antitumor responses in previously resistant
- cold
- tumors.
- Combining innate immune activation with adaptive immune strategies, such as ICIs, holds potential for broader and more durable cancer treatment benefits.
- Further research into innate immune-oncology combinations could significantly improve patient outcomes across various malignancies.
Related Concept Videos
01:27Tumor Immunotherapy
860
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
860
02:57Targeted Cancer Therapies
8.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.1K
01:27Cytotoxic T Cells-mediated Immune Response
6.0K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.0K
01:30Cancer Vaccines
624
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
624
01:28Cells of the Innate Immune Response
7.9K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
7.9K
02:50Combination Therapies and Personalized Medicine
5.6K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.6K